Standing Cognition and Co-morbidities of POTS Evaluation
SCOPE
1 other identifier
interventional
139
1 country
1
Brief Summary
The purpose of this study is to evaluate cognition in patients with postural tachycardia syndrome (POTS) while lying down and standing and to assess the prevalence of hypermobile Ehlers-Danlos Syndrome in POTS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2018
CompletedFirst Submitted
Initial submission to the registry
July 9, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2019
CompletedResults Posted
Study results publicly available
April 14, 2021
CompletedApril 14, 2021
March 1, 2021
1.5 years
July 9, 2018
July 21, 2020
March 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Executive Function (Stroop Word-color Test)
Testing scores are normalized using T-scores for predicted values based on age and education for each participant. Scores range from 0 to 100. Higher numbers indicate better cognition. Testing will be performed while participants are supine and standing.
1 hour
Secondary Outcomes (3)
Attention Score Using Cogstate Identification Task
1 hour
Number of Participants With Hypermobile Ehlers-Danlos Syndrome (hEDS)
1 hour
Heart Rate Standing Minus Heart Rate Supine
1 hour
Study Arms (2)
Standing
EXPERIMENTALParticipants will complete cognitive testing while standing.
Supine
ACTIVE COMPARATORParticipants will complete cognitive testing while supine.
Interventions
Eligibility Criteria
You may qualify if:
- Previously diagnosed with POTS, or healthy control
- Age between 13-60 years
- Participants may be any race, ethnicity, sex, or gender
- Able and willing to provide informed consent
You may not qualify if:
- Inability to give, or withdrawal of, informed consent
- Age ≤ 13 or ≥ 61 years
- Prisoners
- Unable to stand
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Milton S. Hershey Medical Centerlead
- Dysautonomia Internationalcollaborator
Study Sites (1)
Penn State College of Medicine
Hershey, Pennsylvania, 17111, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Amanda J. Miller
- Organization
- Pennsylvania State University College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Amanda J Miller, Ph.D.
Penn State College of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Fellow
Study Record Dates
First Submitted
July 9, 2018
First Posted
July 26, 2018
Study Start
June 23, 2018
Primary Completion
December 17, 2019
Study Completion
December 17, 2019
Last Updated
April 14, 2021
Results First Posted
April 14, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share